Woojung Lee is an experienced professional specializing in health economics and decision modeling. As the Associate Director at the Institute for Clinical and Economic Review since May 2024, Woojung Lee brings a wealth of expertise from previous roles, including Associate at Analysis Group, where contributions involved economic evaluations and health technology assessment strategies for pharmaceutical stakeholders. At Curta, leadership in a significant analysis of administrative claims data demonstrated the value of Botox treatment timing. Time spent at the University of Washington fostered research skills in machine learning applications and real-world evidence in economic assessments. Academic credentials include a PhD in Comparative Health Outcomes, Policy, and Economics from the University of Washington and a PharmD from Seoul National University.
This person is not in any teams